These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6164252)

  • 1. Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.
    Tuna JL; Correia MJ; d'Almeida VC; Mourão L; da Costa FL; Ribeiro C
    Acta Med Port; 1980 Dec; Suppl 1():27-32. PubMed ID: 6164252
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of antiarrhythmic drugs in prevention of sudden cardiac death.
    Podrid PJ
    Cardiovasc Clin; 1985; 15(3):265-86. PubMed ID: 2421903
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of the hyperkinetic response to exercise after myocardial infarct. Results of a randomized ergometric study].
    Opasich C; Griffo R; Cobelli F; Assandri J; Tramarin R; Larovere MT; Vecchio C
    Minerva Cardioangiol; 1982; 30(7-8):395-403. PubMed ID: 6752752
    [No Abstract]   [Full Text] [Related]  

  • 4. [Amiodarone and secondary prevention. The EMIAT study].
    Munoz A
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():67-9. PubMed ID: 1726998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Infarction Study (E.I.S.). A secondary prevention study with slow release oxprenolol after myocardial infarction: morbidity and mortality.
    Eur Heart J; 1984 Mar; 5(3):189-202. PubMed ID: 6373264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mexiletine: double-blind comparison with procainamide in PVC suppression and open-label sequential comparison with amiodarone in life-threatening ventricular arrhythmias.
    Nademanee K; Feld G; Hendrickson J; Intarachot V; Yale C; Heng MK; Singh BN
    Am Heart J; 1985 Nov; 110(5):923-31. PubMed ID: 3904380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empiric long-term amiodarone prophylaxis following myocardial infarction. A meta-analysis.
    Zarembski DG; Nolan PE; Slack MK; Caruso AC
    Arch Intern Med; 1993 Dec; 153(23):2661-7. PubMed ID: 7504440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone in the management of atrial fibrillation complicating myocardial infarction.
    Cowan JC; Gardiner P; Reid DS; Newell DJ; Campbell RW
    Br J Clin Pract Suppl; 1986 Apr; 44():155-63. PubMed ID: 3089255
    [No Abstract]   [Full Text] [Related]  

  • 9. [Implantable automatic defibrillator after MADIT and EMIAT].
    Farré J
    Rev Esp Cardiol; 1996 Oct; 49(10):709-13. PubMed ID: 9036472
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of cordarone (amiodarone) on the circulatory system of patients with recent myocardial infarction].
    Markiewicz M; Kutarski A; Kudlicki J
    Kardiol Pol; 1983; 26(1):33-8. PubMed ID: 6876531
    [No Abstract]   [Full Text] [Related]  

  • 11. The FDA's critique of the anturane reinfarction trial.
    Temple R; Pledger GW
    N Engl J Med; 1980 Dec; 303(25):1488-92. PubMed ID: 7432418
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness of amiodarone in patients with exercise-induced angina pectoris].
    Poprawski K; Parczewska T; Szyszka A; Jankowski J; Wrabec K; Jasiński K
    Kardiol Pol; 1986; 29(1):26-34. PubMed ID: 3522998
    [No Abstract]   [Full Text] [Related]  

  • 13. European infarction study (EIS). A secondary prevention study with slow release oxprenolol after myocardial infarction.
    Eur Heart J; 1982 Dec; 3(6):583-6. PubMed ID: 6761123
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of amiodarone treatment on the myocardial infart size in experimental dogs].
    Cao J
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Mar; 12(1):51-4. PubMed ID: 6745072
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of cordarone in acute myocardial infarct].
    Gol'dberg GA; Nesterov IuI
    Kardiologiia; 1982 Oct; 22(10):107-8. PubMed ID: 6757520
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of previous administration of amiodarone on the early incidence of ventricular fibrillation during experimental myocardial ischemia].
    Spadaro J; Hashimoto LM; Franco RS; Bregagnollo EA; Tucci PJ
    Arq Bras Cardiol; 1984 Jan; 42(1):25-9. PubMed ID: 6743037
    [No Abstract]   [Full Text] [Related]  

  • 17. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].
    Arós Borau F; Loma-Osorio A; Torres Bosco A
    Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oxprenolol on ventricular arrhythmias: the European Infarction Study experience.
    Bethge KP; Andresen D; Boissel JP; von Leitner ER; Peyrieux JC; Schröder R; Tietze U
    J Am Coll Cardiol; 1985 Nov; 6(5):963-72. PubMed ID: 2413097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of sudden cardiac death risk factors after myocardial infarction. III. Changes in biochemical and humoral homeostasis and cardiac rhythm disorders].
    Dłuzniewski M; Gebalska J; Jurgiel R; Kłoś J
    Kardiol Pol; 1987; 30(3):144-50. PubMed ID: 2443741
    [No Abstract]   [Full Text] [Related]  

  • 20. An early intervention secondary prevention study with oxprenolol following myocardial infarction.
    Eur Heart J; 1981 Oct; 2(5):389-93. PubMed ID: 7037414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.